Phlow Corp. applauds the Executive Order issued by the President of the United States to ensure American pharmaceutical supply chain resiliency by ...

Phlow and Antheia established this partnership in 2024 to leverage Antheia's biosynthesis platform for the domestic production of several key starting materials (KSMs) that support Phlow's ...

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

Phlow's Series C funding coincides with several significant milestones this year, including the two newly operational U.S.-based cGMP manufacturing facilities, capable of producing APIs at both ...

Richmond, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its ...

Richmond, VA, July 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of ...

Richmond, Virginia, April 22, 2025 (GLOBE NEWSWIRE) -- Phlow Corp., a leading pharmaceutical contract development and manufacturing organization (CDMO) in America, announced today a significant ...

Phlow developed a manufacturing method leveraging novel chemistry that streamlines production, reducing both waste and manufacturing costs, while making the production of Epinephrine on U.S. soil cost ...